Abbreviated name: FTR
Synonyms: BMS-663068 | BMS663068 | compound 35 [PMID: 29271653] | GSK-3684934 | GSK3684934 | Rukobia®
fostemsavir is an approved drug (FDA (2020), EMA (2021))
Compound class:
Synthetic organic
Comment: Fostemsavir is a phosphonooxymethyl prodrug of temsavir (BMS-626529) [4-5]. It is classified as an attachment inhibitor [2]. Temsavir binds to HIV envelope glycoprotein 120 (gp120) and thereby blocks viral attachment to the host CD4 molecule on T-lymphocytes. Naturally ocurring HIV-1 gp120 polymorphisms that could impart resistance to fostemsavir are uncommon [1].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2020), EMA (2021)) |
IUPAC Name |
[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate |
International Nonproprietary Names | |
INN number | INN |
10292 | fostemsavir |
Synonyms |
BMS-663068 | BMS663068 | compound 35 [PMID: 29271653] | GSK-3684934 | GSK3684934 | Rukobia® |
Database Links | |
CAS Registry No. | 864953-29-7 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3301594 |
DrugBank Ligand | DB11796 |
DrugCentral Ligand | 5401 |
GtoPdb PubChem SID | 434122161 |
PubChem CID | 11319217 |
Search Google for chemical match using the InChIKey | SWMDAPWAQQTBOG-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SWMDAPWAQQTBOG |
Search PubMed clinical trials | fostemsavir |
Search PubMed titles | fostemsavir |
Search PubMed titles/abstracts | fostemsavir |
UniChem Compound Search for chemical match using the InChIKey | SWMDAPWAQQTBOG-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SWMDAPWAQQTBOG-UHFFFAOYSA-N |